Savara Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACLX
Arcellx, Inc. |
$75.01 | $2.72 B | -49.3 | 163 | $107.94 M |
ALXO
ALX Oncology Holdings Inc. |
$1.79 | $469.42 M | -2.43 | 80 | $0 |
ANAB
AnaptysBio, Inc. |
$15.30 | $640.07 M | -3.82 | 136 | $91.28 M |
AVTE
Aerovate Therapeutics, Inc. |
$2.70 | $597.48 M | -6.84 | 30 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$50.49 | $3.53 B | -11.86 | 437 | $1.04 M |
CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 | $0 |
DYN
Dyne Therapeutics, Inc. |
$24.57 | $3.03 B | -7.77 | 191 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
FENC
Fennec Pharmaceuticals Inc. |
$6.08 | $187.43 M | 171.5 | 29 | $21.25 M |
GPCR
Structure Therapeutics Inc. |
$27.50 | $2.47 B | -23.59 | 163 | $0 |
IKNA
Ikena Oncology, Inc. |
$1.66 | $84.45 M | -1.11 | 14 | $0 |
KZR
Kezar Life Sciences, Inc. |
$6.65 | $49.85 M | -0.49 | 58 | $7.00 M |
LBPH
Longboard Pharmaceuticals, Inc. |
$59.98 | $682.34 M | -7.8 | 50 | $0 |
PTIX
Protagenic Therapeutics, Inc. |
$0.59 | $4.66 M | -0.77 | 1 | $0 |
RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
RZLT
Rezolute, Inc. |
$5.21 | $229.57 M | -5.02 | 64 | $0 |
SRRK
Scholar Rock Holding Corporation |
$42.86 | $758.46 M | -4.55 | 128 | $0 |
STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |
TARA
Protara Therapeutics, Inc. |
$5.85 | $54.98 M | -0.71 | 26 | $0 |
TPST
Tempest Therapeutics, Inc. |
$0.95 | $69.10 M | -1.81 | 17 | $0 |
TRDA
Entrada Therapeutics, Inc. |
$18.05 | $531.37 M | 22.81 | 183 | $210.78 M |
VACC
Vaccitech plc |
$5.00 | $192.73 M | -3.45 | 33 | $44.70 M |
XLO
Xilio Therapeutics, Inc. |
$1.01 | $38.76 M | -0.41 | 73 | $6.34 M |
XOMA
XOMA Corporation |
$26.27 | $279.91 M | -6.14 | 13 | $4.76 M |
XOMAO
XOMA Corporation |
$25.26 | $283.28 M | 25.07 | 13 | $4.76 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
